Ombretta Lenzi

689 total citations
19 papers, 623 citations indexed

About

Ombretta Lenzi is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Ombretta Lenzi has authored 19 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Physiology and 12 papers in Organic Chemistry. Recurrent topics in Ombretta Lenzi's work include Adenosine and Purinergic Signaling (13 papers), Synthesis and Biological Evaluation (10 papers) and Receptor Mechanisms and Signaling (9 papers). Ombretta Lenzi is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Synthesis and Biological Evaluation (10 papers) and Receptor Mechanisms and Signaling (9 papers). Ombretta Lenzi collaborates with scholars based in Italy, Belgium and Denmark. Ombretta Lenzi's co-authors include Vittoria Colotta, Daniela Catarzi, Flavia Varano, Guido Filacchioni, Stefano Moro, Claudia Martini, Maria Letizia Trincavelli, Alessandro Galli, Chiara Costagli and Francesca Deflorian and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Ombretta Lenzi

19 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ombretta Lenzi Italy	16	402	386	303	64	28	19	623
An‐Hu Li United States	14	501 1.2×	383 1.0×	319 1.1×	69 1.1×	18 0.6×	20	818
Ariel S. Gross United States	10	202 0.5×	424 1.1×	385 1.3×	133 2.1×	25 0.9×	10	609
Miriam de Groote Netherlands	12	274 0.7×	343 0.9×	322 1.1×	97 1.5×	12 0.4×	13	565
Lucia Squarcialupi Italy	16	222 0.6×	244 0.6×	171 0.6×	68 1.1×	11 0.4×	18	424
Regina Link Netherlands	6	181 0.5×	221 0.6×	153 0.5×	56 0.9×	17 0.6×	6	354
Jacobus P. D. van Veldhoven Netherlands	16	177 0.4×	493 1.3×	172 0.6×	132 2.1×	106 3.8×	26	658
Lisa C. W. Chang Netherlands	7	239 0.6×	232 0.6×	185 0.6×	54 0.8×	15 0.5×	7	439
Elisabeth Klaasse Netherlands	10	66 0.2×	223 0.6×	110 0.4×	65 1.0×	92 3.3×	11	374
Joanne Lerpiniere United Kingdom	10	242 0.6×	206 0.5×	89 0.3×	44 0.7×	9 0.3×	11	386
Reynalda de Jesus Switzerland	7	149 0.4×	175 0.5×	70 0.2×	49 0.8×	14 0.5×	8	302

Countries citing papers authored by Ombretta Lenzi

Since Specialization

Citations

This map shows the geographic impact of Ombretta Lenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ombretta Lenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ombretta Lenzi more than expected).

Fields of papers citing papers by Ombretta Lenzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ombretta Lenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ombretta Lenzi. The network helps show where Ombretta Lenzi may publish in the future.

Co-authorship network of co-authors of Ombretta Lenzi

This figure shows the co-authorship network connecting the top 25 collaborators of Ombretta Lenzi. A scholar is included among the top collaborators of Ombretta Lenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ombretta Lenzi. Ombretta Lenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Mortensen, Martin, Kenneth T. Kongstad, Ombretta Lenzi, et al.. (2019). Developing New 4-PIOL and 4-PHP Analogues for Photoinactivation of γ-Aminobutyric Acid Type A Receptors. ACS Chemical Neuroscience. 10(11). 4669–4684. 6 indexed citations

Lauriola, Maria Michela, et al.. (2012). Allergic Contact Dermatitis From Depilatory Wax. Dermatitis. 23(3). 126–127. 1 indexed citations

Colotta, Vittoria, Ombretta Lenzi, Daniela Catarzi, et al.. (2012). 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies. European Journal of Medicinal Chemistry. 54. 470–482. 34 indexed citations

Lenzi, Ombretta, Vittoria Colotta, Daniela Catarzi, et al.. (2011). Synthesis, structure–affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 19(12). 3757–3768. 19 indexed citations

Catarzi, Daniela, Ombretta Lenzi, Vittoria Colotta, et al.. (2010). Pharmacological Characterization of Some Selected 4,5-Dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-Hydroxyquinazoline-2,4-diones as (S)-2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic Acid Receptor Antagonists. Chemical and Pharmaceutical Bulletin. 58(7). 908–911. 7 indexed citations

Colotta, Vittoria, Ombretta Lenzi, Daniela Catarzi, et al.. (2009). Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies. Journal of Medicinal Chemistry. 52(8). 2407–2419. 31 indexed citations

Lenzi, Ombretta, Vittoria Colotta, Daniela Catarzi, et al.. (2009). 2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A₃Adenosine Receptor Antagonists: New Insights into the Receptor−Antagonist Recognition. Journal of Medicinal Chemistry. 52(23). 7640–7652. 47 indexed citations

Colotta, Vittoria, Ombretta Lenzi, Daniela Catarzi, et al.. (2008). Novel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: Molecular docking analysis and pharmacological studies. Bioorganic & Medicinal Chemistry. 17(1). 401–410. 19 indexed citations

Colotta, Vittoria, Daniela Catarzi, Flavia Varano, et al.. (2008). Synthesis, ligand–receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 16(11). 6086–6102. 32 indexed citations

10.

Varano, Flavia, Daniela Catarzi, Vittoria Colotta, et al.. (2007). Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: Synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry. 16(5). 2617–2626. 28 indexed citations

11.

Colotta, Vittoria, Daniela Catarzi, Flavia Varano, et al.. (2007). New 2-Arylpyrazolo[3,4-c]quinoline Derivatives as Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies. Journal of Medicinal Chemistry. 50(17). 4061–4074. 50 indexed citations

12.

Lenzi, Ombretta, Daniela Catarzi, Flavia Varano, et al.. (2007). Scouting Human A₃ Adenosine Receptor Antagonist Binding Mode Using a Molecular Simplification Approach: From Triazoloquinoxaline to a Pyrimidine Skeleton as a Key Study. Journal of Medicinal Chemistry. 50(26). 6596–6606. 31 indexed citations

13.

Colotta, Vittoria, Daniela Catarzi, Flavia Varano, et al.. (2006). Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological, and Molecular Modeling Studies. Journal of Medicinal Chemistry. 49(20). 6015–6026. 44 indexed citations

14.

Lenzi, Ombretta, Vittoria Colotta, Daniela Catarzi, et al.. (2006). 4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as New Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies. Journal of Medicinal Chemistry. 49(13). 3916–3925. 50 indexed citations

15.

Colotta, Vittoria, Daniela Catarzi, Flavia Varano, et al.. (2005). Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring. European Journal of Medicinal Chemistry. 40(9). 897–907. 25 indexed citations

16.

Varano, Flavia, Daniela Catarzi, Vittoria Colotta, et al.. (2005). 1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: Synthesis, biological evaluation, and molecular modeling study. Bioorganic & Medicinal Chemistry. 13(19). 5536–5549. 62 indexed citations

17.

Catarzi, Daniela, Vittoria Colotta, Flavia Varano, et al.. (2005). 1,2,4-Triazolo[1,5-a]quinoxaline as a Versatile Tool for the Design of Selective Human A₃Adenosine Receptor Antagonists: Synthesis, Biological Evaluation, and Molecular Modeling Studies of 2-(Hetero)aryl- and 2-Carboxy-Substitued Derivatives. Journal of Medicinal Chemistry. 48(25). 7932–7945. 46 indexed citations

18.

Colotta, Vittoria, Daniela Catarzi, Flavia Varano, et al.. (2004). 1,2,4-Triazolo[4,3-a]quinoxalin-1-one Moiety as an Attractive Scaffold To Develop New Potent and Selective Human A₃ Adenosine Receptor Antagonists: Synthesis, Pharmacological, and Ligand−Receptor Modeling Studies. Journal of Medicinal Chemistry. 47(14). 3580–3590. 62 indexed citations

19.

Catarzi, Daniela, Vittoria Colotta, Flavia Varano, et al.. (2004). 2-Aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 13(3). 705–715. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact